Production (Stage)
Trevi Therapeutics, Inc.
TRVI
$6.29
$0.264.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.80% | 29.71% | -26.30% | -26.19% | -34.55% |
| Total Receivables | -- | 9.69% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.56% | -74.07% | -70.88% | -39.46% | 142.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -48.13% | -28.72% | -63.48% | -60.12% | -55.25% |
| Total Current Assets | 37.59% | 24.99% | -28.33% | -27.30% | -32.78% |
|
|
|||||
| Total Current Assets | 37.59% | 24.99% | -28.33% | -27.30% | -32.78% |
| Net Property, Plant & Equipment | -22.94% | -21.17% | -20.05% | -16.98% | -16.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.51% | -18.18% | -13.80% | 301.47% | 38.22% |
| Total Assets | 36.21% | 24.05% | -28.14% | -26.90% | -32.40% |
|
|
|||||
| Total Accounts Payable | -32.72% | 88.72% | 28.50% | 11.76% | 6.51% |
| Total Accrued Expenses | 81.88% | 83.61% | 98.95% | 60.03% | -18.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.29% | -6.86% | 1.71% | 11.55% | -95.84% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 30.14% | 80.44% | 76.36% | 43.32% | -60.03% |
|
|
|||||
| Total Current Liabilities | 30.14% | 80.44% | 76.36% | 43.32% | -60.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -28.24% | -27.62% | -26.68% | -25.90% | -25.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.24% | 64.18% | 58.11% | 29.34% | -56.99% |
|
|
|||||
| Common Stock & APIC | 23.05% | 20.18% | 4.15% | 3.04% | 1.30% |
| Retained Earnings | -18.94% | -20.04% | -19.16% | -17.34% | -15.51% |
| Treasury Stock & Other | 208.96% | 310.34% | 164.06% | 66.13% | 23.86% |
| Total Common Equity | 37.50% | 20.71% | -34.19% | -30.40% | -28.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.50% | 20.71% | -34.19% | -30.40% | -28.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.50% | 20.71% | -34.19% | -30.40% | -28.90% |
|
|
|||||